EXACT SCIENCES CORP (EXAS) Cash from Investing Activities (2010 - 2025)

Exact Sciences (EXAS) has reported Cash from Investing Activities for 16 consecutive years, with $91.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash from Investing Activities rose 317.61% year-over-year to $91.1 million; the TTM figure through Dec 2025 stood at $195.1 million (up 144.13% YoY), while the FY2025 annual figure was $195.1 million, up 144.13% from the prior year.
• Cash from Investing Activities advanced to $91.1 million in Q4 2025 per EXAS's latest filing, from -$86.5 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $224.9 million in Q2 2025 and bottomed at -$793.8 million in Q2 2021.
• Historically, Cash from Investing Activities has averaged -$60.3 million across 5 years, with a median of -$38.2 million in 2024.
• Annual changes were most pronounced in 2021 — Cash from Investing Activities sank 12341.49% — and 2025, when it surged 317.61%.
• Exact Sciences' Cash from Investing Activities stood at $78.4 million in 2021, then tumbled by 174.15% to -$58.2 million in 2022, then dropped by 14.8% to -$66.8 million in 2023, then soared by 37.29% to -$41.9 million in 2024, then surged by 317.61% to $91.1 million in 2025.
• Business Quant data shows EXAS's Cash from Investing Activities at $91.1 million in Q4 2025, -$86.5 million in Q3 2025, and $224.9 million in Q2 2025.